DRKS00023315
Recruiting
Not Applicable
Patient specific drug screening and biomarker research in pancreatic ductal adenocarcinoma using newly established tumoroids - Tumoroids
niversitätsklinikum Hamburg-Eppendorf0 sites50 target enrollmentMarch 26, 2021
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- C25
- Sponsor
- niversitätsklinikum Hamburg-Eppendorf
- Enrollment
- 50
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •PDAC, sufficient tumor material during pathological processing available, written consent
Exclusion Criteria
- •tumor material too small in pathological processing, no written consent
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Validation study of biomarker for Medication-related Osteonecrosis of Jaw (MRONJ)KCT0004294Ewha Womans University Medical Center87
Completed
Not Applicable
Evaluation of Biomarkers among Patients Undergoing Bronchial Thermoplastysevere asthmaJPRN-UMIN000031202ational Hospital Organization Tokyo National Hospital26
Completed
Not Applicable
Search for new biomarkers using disease patient samplesCrohn's disease patient, IBS patient, Healthy subjectsJPRN-UMIN000052411Meiji Co., Ltd.60
Recruiting
Not Applicable
Identification of novel biomarkers for screening, diagnosis, and prediction of renal prognosis in kidney diseases - Multicenter prospective study - (INSPIRE study)Kidney diseasesJPRN-UMIN000033983Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences6,000
Completed
Not Applicable
The psychological health benefits of mindfulness-based stress reduction in family caregivers of patients with dementiaSelf-perceived stress, depression, burden and grief in non-professional caregivers of dementia patientsMental and Behavioural DisordersISRCTN53169488Icahn School of Medicine at Mount Sinai (USA)20